Related references
Note: Only part of the references are listed.Imaging of Inflammation by PET, Conventional Scintigraphy, and Other Imaging Techniques
Martin Gotthardt et al.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY (2013)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Magnitude of Enhanced Permeability and Retention Effect in Tumors with Different Phenotypes: 89Zr-Albumin as a Model System
Carola Heneweer et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
Jason P. Holland et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab
Jason P. Holland et al.
PLOS ONE (2010)
Imaging of Inflammation by PET, Conventional Scintigraphy, and Other Imaging Techniques
Martin Gotthardt et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Standardized methods for the production of high specific-activity zirconium-89
Jason P. Holland et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Dissecting the role of PtdIns(4,5)P2 in endocytosis and recycling of the transferrin receptor
Namiko Abe et al.
JOURNAL OF CELL SCIENCE (2008)
Molecular scintigraphic imaging using 99mTc-transferrin is useful for early detection of synovial inflammation of collagen-induced arthritis mouse
Sang-Il Lee et al.
RHEUMATOLOGY INTERNATIONAL (2008)
siRNA screen of the human signaling proteome identifies the PtdIns(3,4,5) P-3-mTOR signaling pathway as a primary regulator of transferrin uptake
Thierry Galvez et al.
GENOME BIOLOGY (2007)
Regulation of transferrin recycling kinetics by PtdIns[4,5]P2 availability
Sunyun Kim et al.
FASEB JOURNAL (2006)
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer
Tracy R. Daniels et al.
CLINICAL IMMUNOLOGY (2006)
Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis
KA O'Donnell et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line
PA Watson et al.
CANCER RESEARCH (2005)
Myc-driven murine prostate cancer shares molecular features with human prostate tumors
K Ellwood-Yen et al.
CANCER CELL (2003)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Share Paper
